Purine metabolism and uric acid
Guanylates are nucleotides that the body breaks down into purines, ultimately producing uric acid. At food-use concentrations the contribution to dietary purine load is modest, but for people already prone to high uric acid the cumulative effect of regularly eating guanylate-enriched processed foods is relevant. Gout attacks are triggered by uric acid crystals forming in joints, so clinicians advise people with gout to limit all high-purine sources including nucleotide additives.
Dietary purines, including those from guanylate nucleotides, are metabolised to uric acid via xanthine oxidase; elevated serum uric acid is a direct driver of gout and can worsen hyperuricaemia in susceptible individuals.
2005ObservationalChoi HK et al., Annals of the Rheumatic Diseases
The European Food Safety Authority notes that guanylates are generally used at low levels and that no numerical ADI has been set; however, they acknowledge that individuals with conditions affecting purine metabolism should treat guanylate-containing foods with caution.
Regulatory reviewEFSA Panel on Food Additives and Nutrient Sources (ANS)
Dietary exclusion groups
Commercial guanylates can be derived from dried fish (sardines or bonito) as well as from yeast RNA. Fish-derived production means the additive is not vegetarian or vegan unless the manufacturer specifies a yeast or fermentation source. This is not declared on UK labels; the source is not required to be stated alongside the E number.
Guanylates (E626-E629) may be produced from either yeast RNA or from fish-derived sources (sardines, bonito flakes); source is not mandated on the product label under UK/EU food information law.
RegulatoryUK FSA approved-additives list guidance notes
Umami synergy at low concentrations
The synergistic effect between guanylates and glutamates is well-characterised. GMP can amplify the perceived umami intensity several-fold when combined with glutamate, allowing manufacturers to reduce glutamate levels. There is no established health concern arising from this synergistic mechanism itself.
GMP and IMP (inosine 5'-monophosphate) act as positive allosteric modulators of the T1R1/T1R3 umami receptor, amplifying glutamate-induced responses by factors of 5 to 30 depending on concentration.
2008LabZhang F et al., Proceedings of the National Academy of Sciences